Creation of a long-acting nanoformulated dolutegravir
Brady Sillman(University of Nebraska Medical Center), Howard E. Gendelman(Nebraska Medical Center)
Cited by 129
Related Papers
Diagnostics for SARS-CoV-2 infections
|Nature Materials|2021|838
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
|PLoS ONE|2008|360
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
|Nature Communications|2019|296
Human Immunodeficiency Virus type 1 Endocytic Trafficking Through Macrophage Bridging Conduits Facilitates Spread of Infection
|Journal of Neuroimmune Pharmacology|2011|91
The potential for treg-enhancing therapies in nervous system pathologies
|Clinical & Experimental Immunology|2022|49